Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
8823cover1_open440.jpg

June 7, 2010 Cover

Volume 88, Issue 23

The spending race is over in pharmaceutical R&D, with companies now focused on doing more with less

Credit:

Full Article
Volume 88 | Issue 23

All Issues

Business

Research Recalibrated

The spending race is over in pharmaceutical R&D, with companies now focused on doing more with less

  • Enzyme’s Metal Cluster Is Nailed

    Definitive solution of the structure of an enzyme in isoprenoid biosynthesis could lead to new antibiotics

  • Eastman Finds Its Stride

    Executives have sworn off reinvention, instead focusing on what they think the company does best

  • Health Agencies Under Scrutiny

    Congress, GAO point to consistent flaws in CDC units' environmental health practices

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT